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Differential connexin expression in preglomerular and post-
glomerular vasculature: Accentuation during diabetes.
Background. Gap junctions may play an important role in
regulating renal blood flow and glomerular responses. We have
therefore made a comprehensive analysis of connexin expres-
sion in the renal vasculature of control and diabetic mice since
elevated glucose has been reported to down-regulate connexin
43 in vascular cells in vitro.
Methods. Connexin distribution was determined with im-
munohistochemistry using subtype-specific and cell type–
specific antibodies. Diabetes was induced with streptozotocin
(120/80 mg/kg, intraperitoneally) in C57BL/6 mice.
Results. Connexins 37, 40, and 43 were expressed in endothe-
lial cells of the renal, lobar, arcuate, and interlobular arteries
and afferent arterioles, although connexin 43 was weak in the
renal and arcuate arteries. Connexin 37 was detected in the
media of arcuate, interlobular arteries and afferent arterioles
and connexins 37 and 40 were found in renin-secreting cells.
Both connexins 37 and 40 were expressed in extraglomerular
mesangial cells, connexin 40 was abundantly expressed in in-
traglomerular mesangial cells, but connexin 37 was limited to
mesangial cells at the vascular pole. In contrast, only connexin
43 was detected in endothelial cells of efferent arterioles and
there was no connexin staining in the media. In diabetes, con-
nexin 40 was expressed in smooth muscle cells along afferent ar-
terioles, glomerular connexin staining was more extensive and
connexin 43 was detected in renin-secreting cells. In contrast
connexin 43 expression in endothelial cells of efferent arteri-
oles was markedly reduced.
Conclusion. The renal vasculature and mesangial cells are
well coupled on the preglomerular side but there is little evi-
dence that the coupling extends into the efferent arteriole. This
pattern of cell coupling is accentuated during diabetes.
Regulation of renal blood flow (RBF) and glomeru-
lar filtration rate (GFR) depend not only on renal resis-
tance vessels, which include the arcuate and interlobular
arteries, afferent and efferent arterioles, and descending
vasa recta [1], but also on a feedback mechanism termed
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tubuloglomerular feedback response [2]. During the lat-
ter response, changes in salt concentration in the distal
tubule are sensed by the macula densa cells and this pro-
duces vasoconstriction of the afferent arteriole leading to
decreased glomerular flow and filtration rate [2]. While
nitric oxide may be instrumental in the initiation of the
tubuloglomerular feedback response [3], gap junctions
are likely to play an important role in the transfer of infor-
mation through the intervening mesangial cells to the af-
ferent arteriole [4, 5]. In order to coordinate responses in
adjacent nephrons, the vasoconstrictor response needs to
be conducted upstream into and along interlobular arter-
ies. Such conduction of vasomotor responses along renal
vessels has been observed in the split hydronephrotic rat
kidney [6] and coupling between neighboring nephrons
has also been demonstrated in normal and hypertensive
rats [7, 8]. Studies of the mechanisms underlying the con-
duction of vasomotor responses in other vascular systems
have provided strong evidence in favor of a crucial role for
electric coupling through gap junctions in the endothe-
lium and smooth muscle in these phenomena [9–11].
At the ultrastructural level, gap junctions have been
shown to exist between endothelial cells, smooth muscle
cells, and between the two cellular layers in interlobu-
lar arteries and afferent arterioles [12, 13].Gap junctions
have also been found among and between intraglomeru-
lar mesangial cells and extraglomerular mesangial cells
[14–16] and to form in vitro between renin-secreting cells,
smooth muscle, and endothelial cells [17]. Accordingly,
nine connexin subtypes are reported to be expressed at
the mRNA level: connexins 26, 30.3, 31, 32, 37, 40, 43,
45, and 46 [18, 19]. However, a comprehensive analysis
of connexin protein expression, other than connexin 40
[20–22], has not been made in the renal vasculature. Fur-
thermore, no reports are available regarding changes in
connexin expression during diabetes mellitus, although
inhibition of gap junctional intercellular communication
and down-regulation of connexin 43 expression by high
glucose has been described in cultured microvascular en-
dothelial cells and aortic smooth muscle cells [23, 24]. The
aim of the present study was therefore to investigate the
expression of the vascular connexin proteins, connexins
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37, 40, and 43 in the renal vasculature and juxtaglomeru-
lar apparatus of wild-type C57BL/6 mice and to study
whether any changes occur to connexin expression dur-
ing diabetes.
METHODS
Tissue preparation
All procedures were conducted in accordance with the
Australian Code of Practice for the Care and Use of An-
imals for Scientific Purpose, under a protocol approved
by the Animal Experimentation Ethics Committee of the
Australian National University.
Male C57BL/6 mice aged 10 to 16 weeks (N =
20) were deeply anaesthetized (5 mg/kg xylazine and
25 mg/kg ketamine, intraperitoneally). For cryosec-
tions, fresh kidneys were removed into dissecting buffer
containing (mmol/L): 3 3-N-morpholinopropanesulfonic
acid (MOPS); 1.2 NaH2PO4; 145 NaCl; 4.7 KCl; 2 CaCl2;
1.2 MgSO4; 2 pyruvate; 0.02 ethylenediaminetetraacetic
acid (EDTA) (sodium); 4.6 glucose; and 0.15 albumin.
The kidney capsule was removed and the kidney sliced
transversely into 1 mm blocks and fixed in cold acetone
at 4◦C for 30 minutes. This fixation regime produced op-
timal staining for all three antibodies used in this study.
Tissue blocks were then washed with phosphate-buffered
saline (PBS) (2 × 15 minutes), immersed in 30% sucrose
in PBS at 4◦C overnight, and embedded in Cryo-M-Bed
(Bright Instrument Company, Cambridge, UK). Coronal
sections were cut (10 lm and 30 lm), mounted on slides
coated with silane (2%, Sigma-Aldrich, Sydney, NSW,
Australia), dried for 30 minutes over phosphorus pen-
toxide, and stored frozen.
For whole-mount preparations of larger renal arteries,
including renal, lobar, and arcuate arteries, mice were per-
fused with normal saline containing 0.1% bovine serum
albumin (BSA)/0.1% NaNO2 via the left ventricle at a
pressure of 60 mm Hg to maximally dilate blood vessels.
Dilated blood vessels were then fixed in situ by perfusion
with 2% paraformaldehyde in 0.1 mol/L PBS for 10 min-
utes. Kidneys with attached renal arteries were removed
into PBS. Renal arterial trees were carefully dissected
up to the interlobular arteries, pinned in a Sylgard (Dow
Corning, Midland, MI, USA) coated Petri dish and the
renal, lobar, and arcuate arteries were cut open longitu-
dinally.
Immunohistochemistry
Frozen slides were brought to room temperature and
all the following procedures were done at room tempera-
ture. Tissues were preincubated for 30 minutes in a block-
ing solution containing 2% BSA (or 2% of the serum
of the secondary antibody) and 0.2% Triton in PBS, fol-
lowed by 48 hours incubation in sheep antirat connexin
37 and connexin 40 [25] (1:250), rabbit antirat connexin
43 (Zymed Laboratories, Inc., San Francisco, CA, USA)
(1:250 for cryosections and 1:100 for whole mounts of re-
nal, lobar, and arcuate arteries) in the same solution in
a humidified chamber. These three antibodies have been
previously tested for specificity against the relevant con-
nexin subtype using Western blotting and immunohisto-
chemistry of COS-7 cells transfected with plasmid DNA
encoding either connexins 37, 40, and 43 [26]. Tissues
were rinsed sequentially with normal PBS for 10 minutes,
high-salt PBS (450 mmol/L NaCl in PBS) for 5 minutes,
and normal PBS (2 × 15 minutes), then incubated in Cy3-
conjugated antigoat (Jackson ImmunoResearch Labora-
tories, Inc., West Grove, PA, USA) (1:600) or antirab-
bit (Jackson ImmunoResearch Laboratories, Inc.) (1:100)
antibodies in 0.3% Triton in PBS for 2 hours.
In order to determine the cellular site of connexin
expression, sections were double labeled with either
rabbit antimyosin (U. Gro¨schel-Stewart, Technische Uni-
versitat, Darmstadt, Germany) (1:250) for 1 hour, or rab-
bit antihuman von Willebrand factor (anti-VWF) (Dako,
Glostrup, Denmark) (1:300) for 1 hour, or rabbit an-
tineuronal nitric oxide synthase (anti-nNOS) (Zymed
Laboratories) (1:100) overnight to label vascular smooth
muscle cells, endothelial cells, and macula densa cells,
respectively. Subsequent detection was achieved with
fluorescein isothiocyanate (FITC)-conjugated anti-rabbit
(Dako) (1:40) antibody in 0.3% Triton in PBS for 1 hour.
Tissues were mounted in buffered glycerol and viewed
with a confocal laser scanning microscope and Argon/
Kryton laser (TCS 4D) (Leica Instruments, Vienna, Aus-
tria). Series of images were collected in the Z axis at 1
lm intervals to encompass entire blood vessels and re-
combined to a single image. For double-labeled sections,
either single images or image series were combined in two
colors using Adobe Photoshop as indicated. For compar-
isons of staining between diabetic and control mice, sec-
tions were mounted on the same slides and for any one
connexin antibody, comparative images were obtained
using the same pinhole and voltage settings. In order to
determine the extent of nonspecific staining, tissue sec-
tions were treated with solutions from which the primary
antibody was omitted or solutions containing primary an-
tibody which had been preincubated for 1 hour at room
temperature with the appropriate antigenic peptide.
Morphologic identification and analysis
Afferent arterioles were distinguished from efferent
arterioles by their larger size, connection to larger inter-
lobular arteries, and absence of branching before enter-
ing the glomerulus [27]. Extraglomerular mesangial cells
were identified by their position between afferent arteri-
oles and efferent arterioles and close relationship to mac-
ula densa cells labeled with anti-nNOS [2]. Measurement
of diameter of renal arterioles was based upon myosin
staining.
Quantification of connexin staining was made on con-
focal images of the afferent arterioles (connexins 37, 40,
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and 43), efferent arterioles (connexin 43), and glomeruli
(connexin 37 and 40) using the software program, An-
alytic Imaging Station 3.0 (AIS, Imaging Research, St
Catharines, Ontario, Canada) and the grain counting
function in which a background level of staining could be
defined. The amount of connexin staining was expressed
as the percentage of the scan area occupied by staining,
(i.e., levels greater than background). Scanned areas were
defined by the edges of the arterioles or the glomeruli.
Using this method, it was not possible to distinguish be-
tween endothelial staining and smooth muscle staining.
In the case of analysis for connexin 40 within afferent
arterioles, the staining in two different areas was mea-
sured. Afferent arteriole 1 refers to regions of afferent
arterioles within 40 lm of the glomerulus, while afferent
arteriole 2 refers to regions of afferent arterioles further
than 40 lm from the glomerulus. In the case of analyses
of afferent arterioles for connexin 37 and connexin 43,
no distinction was made as preliminary data showed that
staining in these two areas was indistinguishable.
All data were expressed as means ± SEM. Student
t test was used to compare paired or unpaired data and
statistical significance was set at P < 0.05.
Diabetes protocol
Wild-type adult male C57BL/6 mice (8 to 10 weeks
old) were housed at room temperature with a
12-hour light/dark cycle and allowed free access
to standard mice chow and drinking water. Dia-
betes was induced by intraperitoneal injections of
streptozotocin [2-deoxy-(3-methyl-3-nitrosoureido)-D-
glucopyranose] (Calbiochem, Darmstadt, Germany) in
0.2 mol/L acetate-buffered saline (pH 4.4) on two consec-
utive days (120 mg/kg body weight). After 48 hours, if dia-
betes had not developed, another two injections of strep-
tozotocin (80 mg/kg body weight) were given over 2 days.
Capillary blood glucose concentration was assessed using
a Medisense blood glucose electrode sensor (Abbott Lab-
oratories, Victoria, Doncaster, Australia). Diabetes was
defined as a nonfasting capillary blood glucose concen-
tration ≥18 mmol/L on 2 consecutive days. Gender- and
age-matched C57BL/6 mice injected with acetate buffer
only were used as control.
After establishment of diabetes, nonfasting capillary
blood glucose concentration and body weight were mon-
itored at least twice a week throughout the study period.
If weight loss was greater than 1 mg/day, an intraperi-
toneal supplement of 0.9% saline was given. We defined
1 to 2 weeks, 4 to 6 weeks, and 8 to 10 weeks after es-
tablishment of diabetes as early, intermediate, and late
stages of diabetes. At each diabetic stage, four control
and four diabetic mice were deeply anaesthetized and
their kidneys were processed for immunohistochemistry.
The mice were killed by exsanguination.
RESULTS
Size difference in arteriolar diameter
The diameter of afferent arterioles from superficial
glomeruli was significantly greater (16.81 ±1.08 lm) (N =
5) (P < 0.05) than that of efferent arterioles (13.43 ± 1.11
lm) (N = 5). However, the diameter of afferent arterioles
from juxtamedullary region was similar (17.62 ± 0.65 lm)
(N = 4) (P > 0.05) to that of muscular efferent arterioles
(16.73 ± 0.63 lm) (N = 4).
Connexin staining in control kidneys
No significant difference in Connexin staining was
noted in any of the renal structures studied during the
period of these experiments from 10 to 16 weeks of age
in control mice.
Extra- and intrarenal arteries
In the endothelium of larger renal arteries, including
the renal artery and lobar artery, bright, punctate stain-
ing for connexin 37 (Fig. 1A) and connexin 40 (Fig. 1B)
was found while staining for connexin 43 was weak and
irregular (Fig. 1C). None of the three connexins were de-
tected in the smooth muscle cells of these arteries. The
expression of connexins 37, 40, and 43 was similar in the
endothelial cells of the arcuate and interlobular arteries,
being intense for connexin 37 (Figs. 2A and 3A), and
connexin 40 (Figs. 2B and 3B), and weak for connexin
43 (Figs. 2C and 3C). In contrast to the renal and lobar
arteries, in the smooth muscle cells of both the arcuate
and interlobular arteries, connexin 37 could be detected,
although there was no evidence for connexins 40 or 43
(Figs. 2 and 3).
Juxtaglomerular apparatus
In the afferent arterioles, double-labeled with an-
timyosin, bright, punctate staining of connexin37 (Fig. 4A
and B), connexin 40 (Fig. 4C and D), and connexin 43
(Fig. 4E and F) was detected along the endothelial cells.
In each case staining was continuous to the entrance to
the glomerulus (Fig. 5A, B, and E), underlying all of the
smooth muscle staining. In contrast, neither connexin 37
(Fig. 4A) nor connexin 40 (Fig. 4C) was detected in the
endothelium of the efferent arterioles. However, we con-
sistently detected connexin 43 staining (Figs. 4E and 5F)
in the endothelium of the efferent arterioles. This staining
was equal to or slightly less extensive than that of the af-
ferent arterioles (see Fig. 10C). Connexin 43 staining was
also detected around the superficial cortical peritubular
capillaries (Fig. 4E). No differences in connexin 37, con-
nexin 40, and connexin 43 staining were detected between
arterioles supplying the superficial glomeruli and the jux-
tamedullary glomeruli.
1174 Zhang and Hill: Differential connexin expression in renal vasculature
Renal Artery
Fig. 1. Connexin (Cx) expression in the renal artery. Cx37 (A), Cx40
(B), and Cx43 (C) were found in the endothelium of renal artery. The
longitudinal axis of the vessels runs left to right. No connexins were
detected in the smooth muscle cells (scale bar represents 25 lm).
Arcuate artery
Fig. 2. Connexin (Cx) expression in the arcuate artery. Cx37 (A), Cx40
(B), and Cx43 (C) were found in the endothelium of the arcuate artery.
The longitudinal axis of the vessels runs left to right. Connexin 37 was
also expressed along the edges of the smooth muscle cells (A). In (C),
the arcuate artery was cut open along its length. Abbreviations are: ec,
endothelial cells; smc, smooth muscle cells [scale bar represents 25 lm
in (A), 50 lm in (B and C)].
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Interlobular artery
Fig. 3. Connexin (Cx) expression in the interlobular artery. Punctate
staining of Cx37 was found in the endothelium and the smooth muscle
cells (A), while Cx40 (B) and Cx43 (C) were restricted to the endothe-
lium. The longitudinal axis of the vessels runs left to right. Abbrevia-
tions are: ec, endothelial cells; smc, smooth muscle cells; ia, interlobular
artery (scale bar represents 25 lm).
In the smooth muscle cells, connexin 37 staining was
detected in more than 50% of the afferent arterioles
(26/48 of 31 mice) (Fig. 5C). In the section of the af-
ferent arteriole adjacent to the glomerulus, the site of
the renin-secreting cells of the juxtaglomerular appara-
tus, abundant connexin 37 (Fig. 5A) and connexin 40
(Fig. 5B and D) staining was detected in more than 98%
of the afferent arterioles examined (52/53 afferent arte-
rioles of 31 mice), while no connexin 43 (Fig. 5E) was
ever detected. Connexin 40 was generally not found in the
smooth muscle cells of the afferent arterioles, although in
some preparations staining appeared to extend for up to
40 lm beyond the region occupied by the renin-secreting
cells (Figs. 5D and 10B). Connexin 43 was never detected
in the smooth muscle cells of afferent arterioles or renin-
secreting cells (Fig. 5E). In the efferent arterioles, there
was no evidence for any connexin 37, 40, or 43 expression
in the smooth muscle (Figs. 4A and C and 5F). Connexin
43 staining was detected in occasional tubules within the
cortex (Fig. 8E), while connexin 37 and connexin 40 were
not detected in any of the tubular structures.
When the macula densa was double-labeled with anti-
nNOS, extensive staining of connexin 37 (Fig. 6A) and
connexin 40 (Fig. 6B) was observed in the adjacent extra-
glomerular mesangial cells. Staining of connexin 37 and
connexin 40 in the extraglomerular mesangial cells ex-
tended into the glomeruli, forming a continuous staining
pattern between the extraglomerular mesangial cells and
the glomerulus (Fig. 6A to C). While connexin 37 expres-
sion was restricted to the vascular pole (Figs. 6A and 8A),
connexin 40 was present throughout the glomerulus (Figs.
6B and C and 8C). When the afferent and efferent arte-
rioles were labeled with antimyosin, intense connexin 40
staining could be found between them both outside and
inside of the glomerulus (Fig. 6C). No myosin staining was
found within the glomerulus (Fig. 6C) and no connexin
43 was detected in either the extraglomerular mesangial
cells or inside the glomerulus (Fig. 6D). When endothelial
cells were labeled with anti-VWF, staining of connexin 37
(Fig. 6E) and connexin 40 (Fig. 6F) inside the glomerulus
did not overlap with anti-VWF staining, suggesting that
connexin 37 and connexin 40 staining inside the glomeru-
lus was on intraglomerular mesangial cells surrounding
the capillaries. Both connexin 37 and connexin 40 were
detected in the vascular bundles, while connexin 43 was
not seen (not shown).
Table 1 provides a semiquantitative summary of con-
nexin expression in the kidney of normal C57BL/6 mice.
While comparisons of the extent of connexin expression
can be made readily between different renal vessels for
any one antibody, comparison of staining between anti-
bodies is more difficult due to complications which may
arise from differential binding efficiencies.
For each of the connexin antibodies, no staining was
found if the primary antibody was omitted or if the pri-
mary antibody had been preincubated with the antigenic
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Afferent and efferent arterioles
Fig. 4. Connexin (Cx) expression in renal arterioles. When arterioles were labeled with antimyosin (B, D, and F), Cx37 (A) and Cx40 (C) were
detected in the afferent arteriole (aa) but not in the efferent arterioles (ea). In contrast, Cx43 was detected in both arterioles (E) compare (F). Cx43
was also detected outside the interlobular artery (ia), around the cortical tubules (ct, arrowhead), and peritubular capillaries (ptc). Gl is glomerulus
[scale bar represents 25 lm in (A and B) and 50 lm in (C to F)].
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Renal arterioles
Fig. 5. Connexin (Cx) expression in renal ar-
terioles. In afferent arterioles, Cx37 (A), Cx40
(B), and Cx43 (E) were detected in endothe-
lial cells (ec). In the region of the renin-
secreting cells (rsc) adjacent to glomerulus
(gl), Cx37 (A), and Cx40 (B and D) were de-
tected, but not Cx43 (E). In the smooth muscle
cells (smc), Cx37 (C) was detected and occa-
sionally in the smooth muscle cells adjacent to
the renin-secreting cells Cx40 was found (D),
while no Cx43 was found either in the affer-
ent (aa) or efferent arterioles (ea) (E and F)
(scale bar represents 25 lm).
peptide (Fig. 9A, C, and E). Antimyosin staining was used
to mark the location of renal vasculature in these prepa-
rations (Fig. 9B, D, and F). As connexin 43 staining was
often weaker than connexin 37 and connexin 40, acetone-
fixed cardiac muscle was used in addition as a positive
control and incubation with the anticonnexin 43 antibody
produced extensive and intense staining (Fig. 9G). Incu-
bation of the antibody against connexin 43 with peptide
completely eliminated this staining in the heart (Fig. 9H).
Connexin staining in diabetes
In the kidney of mice, 8 to 10 weeks after induction
of streptozotocin-induced diabetes, connexin 37 staining
of both endothelial cells and smooth muscle cells of the
renal vasculature was similar to that of controls (Fig. 7A
vs. Figs. 3A, 5A, and 5C). Quantification of connexin 37
showed no significant difference between afferent arteri-
oles in control and diabetic mice (P > 0.05) (Fig. 10A).
However, inside the glomerulus, there was a significant
expansion of connexin 37 from the vascular pole in con-
trol (Fig. 8A) to the capillary loops of the glomerulus (P <
0.05) (Figs. 8B and 10A) in diabetes.
Connexin 40 staining was detected in the endothelial
cells of the afferent arterioles but not in the efferent ar-
terioles (Fig. 7C) of diabetic mice in a similar fashion
to that seen in control (Fig. 4C). However, connexin 40
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Mesangial cells
Fig. 6. Connexin (Cx) expression in extra- and intraglomerular mesangial cells. Extraglomerular mesangial cells (emc) lying adjacent to the macula
densa (md) labeled with antineuroal nitric oxide synthase (anti-nNOS) (A and B) expressed Cx37 (A) and Cx40 (B). When afferent (aa) and
efferent arterioles (ea) were labeled with antimyosin (C and D), extraglomerular mesangial cells (emc) could be seen to express Cx40 but not
Cx43. When endothelial cells (ec) were labeled with anti-von Willebrand factor (anit-VWF), Cx37 (E) and Cx40 (F) were shown to be expressed
on intraglomerular mesangial cells (imc) (scale bar represents 25 lm).
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Table 1. Distribution of connexin 37, 40, and 43 in murine renal vasculature
Vasculature Connexin subtype Connexin 37 Connexin 40 Connexin 43
Renal artery Endothelial cells +++ +++ +
Smooth muscule cells − − −
Lobar artery Endothelial cells +++ +++ +
Smooth muscle cells − − −
Arcuate artery Endothelial cells +++ +++ +
Smooth muscle cells ++ − −
Interlobular artery Endothelial cells +++ +++ ++/+
Smooth muscle cells ++ − −
Afferent arteriole Endothelial cells +++ +++ ++
Smooth muscle cells ++ +/− −
Renin-secreting cell ++ +++ −
Efferent arteriole Endothelial cells − − ++/+
Smooth muscle cells − − −
Vascular bundles Endothelial cells ++ ++ −
Smooth muscle cells − − −
Mesangial cells Intraglomerular ++/+ +++ −
Extraglomerular +++ +++ −
Abbreviations are: +++, intense, punctate staining; ++, moderate, punctate staining; +, weak, irregular staining; −, no staining.
staining was detected between the smooth muscle cells
in more than 50% of the afferent arterioles (27/53 of
three mice) in diabetes (Fig. 7B to D). Quantification
of connexin 40 staining in regions of afferent arterioles
further than 40 lm from the glomerulus showed a signif-
icant increase in diabetes (P < 0.05) (Fig. 10B) (afferent
arterioles 2), while staining in regions of afferent arteri-
oles within 40 lm was not significantly different between
control and diabetic mice (P = 0.07) (Fig. 10B) (affer-
ent arterioles 1). This increase in smooth muscle staining
was detected only after 4 weeks of diabetes and was most
pronounced after 8 weeks of diabetes. Inside the glomeru-
lus, connexin 40 staining along the capillary loops in con-
trol (Fig. 8C) appeared to extend peripherally in diabetes
(Fig. 8D). However, quantification of connexin 40 stain-
ing showed a trend to an increase in size of the glomeruli
and the area stained, but no significant change in the pro-
portional area occupied by connexin 40 staining (P >
0.05) (Fig. 10B).
A decrease in connexin 43 staining was found in the en-
dothelium of the efferent arterioles in diabetes (Figs. 7E
and 10C). This was first detected in early stages of dia-
betes (2 weeks) in superficial glomeruli and became more
widespread after 8 week of diabetes. At 10 weeks of di-
abetes, clear but irregular connexin 43 staining was first
detected between the renin-secreting cells (Fig. 7F). An
increase of connexin 43 staining in the renal tubules of
the cortex (Fig. 8F) was also detected in diabetic mice
compared to that seen in that of controls (Fig. 8E). Both
the number of labeled tubules and the intensity of the
staining were increased during diabetes.
DISCUSSION
The present study has demonstrated that connexin
37, connexin 40, and connexin 43 are extensively ex-
pressed in endothelial cells and smooth muscle cells of
preglomerular renal vasculature and extra- and intra-
glomerular mesangial cells in C57BL/6 mice. In contrast,
connexin 43 is the only connexin expressed in the post-
glomerular vasculature and this was entirely confined to
the endothelial cells. Our results thus provide strong evi-
dence that the preglomerular vasculature is much better
coupled than previously thought [18, 20–22], in contrast
to the postglomerular vasculature where only weak en-
dothelial coupling could be found.
In endothelial cells of the renal arteries and afferent
arterioles, connexin 37 was strongly expressed. This is
consistent with previous studies showing connexin 37 in
endothelial cells of mouse aorta and renal artery [28–
30], rat renal arteries, caudal artery, and coronary artery
[18, 25, 31]. However, it is in contrast to Seul and Beyer
[22] who failed to detect connexin 37 in renal vascula-
ture of adult B6, SJL f2 mice. This discrepancy might be
explained by different fixation protocols, different anti-
bodies, or different mouse strains. Connexin 40 was also
abundantly expressed in the endothelial cells of the pre-
glomerular renal arteries and arterioles, in agreement
with previous studies in mouse and rat vasculature [22,
25, 31]. In contrast, connexin 43 expression was weak and
irregular in renal, lobar, and arcuate arteries. While con-
nexin 43 was expressed in rat aorta, carotid artery, supe-
rior mesenteric artery, and medium-sized renal arteries
[21, 32], it was not found in the mouse aorta [28], suggest-
ing considerable species differences. Interestingly, as the
vessel size decreased, staining for connexin 43 increased
in the endothelium of renal vessels. Thus endothelial cells
of the renal vasculature, especially the interlobular arter-
ies and afferent arterioles, are well coupled to each other
via connexin 37, connexin 40, and connexin 43. This pro-
vides an efficient communication route through which
vascular responses could be conducted along the smaller
renal arteries leading to changes in renal vascular resis-
tance, RBF, and filtration rate.
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Afferent and efferent arterioles in diabetes
Fig. 7. Changes of connexin (Cx) expression
in diabetic arterioles. No difference in Cx37
was detected between control (see Figures 3A
and 5A and C) and diabetes (10 weeks’ dura-
tion (A) in the afferent arterioles (aa) and in-
terlobular artery (ia). Cx40 was detected only
in the afferent arteriole but not in the efferent
arteriole (ea) (C) in diabetes. Cx40 was fre-
quently detected in the smooth muscle cells
(smc) of the afferent arterioles in diabetes (B,
C, and D). A decrease or absence of Cx43 in
the efferent arteriole was noted in diabetes
(E and F), although Cx43 was detected in the
renin-secreting cells (rsc) in diabetes (F). dm
is diabetes mellitus [scale bar represents 25
lm in (A to D and F) and 50 lm in (E)].
In contrast to the abundance of cell coupling in the
endothelium of afferent arterioles, only connexin 43 was
expressed in the efferent arterioles. Such restricted con-
nexin expression in the endothelium is atypical of that
generally described in arterioles and arteries [18, 21, 22,
33, 34], but accords with the differential expression of
connexin 40 found previously in the afferent and efferent
renal arterioles of mice [22]. Inside the glomerulus, when
endothelial cells were labeled with anti-VWF, we could
not detect any connexin staining in the endothelium of the
glomerular capillary loops suggesting that there is little
or no coupling between endothelial cells of the afferent
arterioles and those of the efferent arterioles. While Seul
and Beyer [22] made a similar suggestion, this was based
on an absence of staining in the endothelium of the distal
portion of the afferent arteriole near the entrance to the
glomerulus. In contrast we found that connexins 37, 40,
and 43 were expressed in the endothelial cells of the af-
ferent arterioles within the juxtaglomerular region of the
glomerulus and suggest that an interruption in coupling
between the preglomerular and postglomerular vascula-
ture may occur within the glomerulus itself.
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Diabetes
Fig. 8. Changes of connexin (Cx) expression
in glomeruli and cortical tubules during dia-
betes for 10 weeks. An intraglomerular expan-
sion of Cx37 was detected in diabetes (B) com-
pared to that in control, where it is restricted
to the vascular pole (A). More intensive and
extensive Cx40 expression was found inside
the glomerulus in diabetes (D) compared to
that in control kidneys (C). The glomerulus (A
to D) was orientated with the vascular pole at
the bottom. An increase in Cx43 was noted in
the cortical tubules in diabetes (F) compared
to that seen in control (E) [scale bar repre-
sents 25 lm in (A to D) and 50 lm in (E and
F)].
In the smooth muscle cells of the arcuate artery,
interlobular artery and afferent arteriole and in the
renin-secreting cells, connexin 37 was clearly expressed
although it was absent from the media of the renal and lo-
bar arteries. Connexin 37 has previously been described
in the media of large rat arteries, like the caudal and coro-
nary arteries [25, 31]. In contrast, Arensbak et al [18]
failed to detect connexin 37 protein expression in pre-
glomerular arteries although they successfully demon-
strated mRNA for connexin 37 in cultured preglomerular
smooth muscle cells. Our results thus provide the first di-
rect evidence of connexin 37 expression in the smooth
muscle cells of small renal arteries and afferent arterioles
and in the renin-secreting cells. We found no evidence for
connexin 43 expression in the media of renal arteries or
arterioles as in rat muscular arteries [32], while connexin
40 was found in the renin-secreting cells and occasion-
ally in the adjacent smooth muscle cells of the afferent
arteriole, consistent with previous studies [18, 21, 22]. In
the efferent arterioles, none of the three connexins was
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M
M
M
Fig. 9. Connexin (Cx) antibody specificity
test. Antibodies against Cx37, Cx40, and Cx43
were preincubated with their corresponding
antigenic peptides before incubation with the
tissue (A, C, and E, respectively) and an-
timyosin (B, D, and F) was used to label the re-
nal vasculature. The staining for Cx37, Cx40,
and Cx43 seen in Figures 4 and 5 was com-
pletely abolished (A, C, and E). Extensive
Cx43 staining found in cardiac muscle (G) was
also completely abolished after peptide block
(H) [scale bar represents 25 lm in (A to F)
and 50 lm in (G and H)].
detected in the smooth muscle cells, consistent with the
absence of gap junctions in electron microscopic studies
[12].
Both extra- and intraglomerular mesangial cells exhib-
ited intense expression of connexin 37 and connexin 40,
while connexin 43 was not found. While this is consistent
with connexin 40 being previously described in mesangial
cells [18], our results provide the first evidence that multi-
ple connexins are expressed at the gap junctions demon-
strated amongst mesangial cells in electron microscopic
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Fig. 10. Quantification of connexin (Cx) staining in renal vasculature
during diabetes. (A) A significant increase in the proportional area of
Cx37 staining was found in glomeruli from diabetic mice. ∗P < 0.05,
compared to control mice. However, there was no change in the Cx37
staining in the afferent arterioles. (B) A significant increase in Cx40
staining was detected in afferent arterioles of diabetic mice when mea-
sured in areas further than 40 lm from the glomeruli. ∗P < 0.05, afferent
arterioles 2. No significant difference was found in Cx40 staining in re-
gions of afferent arterioles within 40 lm of glomeruli (P > 0.05, afferent
arterioles 1), nor was there any difference in the proportional area of
staining within the glomeruli. (C). A significant decrease in Cx43 was de-
tected in the efferent arterioles from diabetic mice. ∗P < 0.05. However,
there was no change in the staining in the afferent arterioles. Symbols
are: (), control; (), diabetes (4 to 10 weeks). Numbers in parentheses
represent the number of arterioles or glomeruli measured from at least
four different mice in each case.
studies [14–16]. These connexins provide a mechanism
by which both extra- and intraglomerular mesangial cells
can behave as a functional syncytium [35]. Electrophysio-
logic studies have shown that mesangial cells are essential
for the transfer of information from the macula densa to
afferent arterioles [4, 5]. The abundant connexin expres-
sion in the afferent arteriole and mesangial cells suggests
a direct communication route for the tubuloglomerular
feedback response without the need for further chemical
mediators.
Extensive connexin expression in the afferent arteri-
oles and interlobular arteries provides a mechanism for
the coordination of RBF and GFR seen between adja-
cent nephrons [7, 36], through the ability of afferent ar-
terioles and interlobular arteries to conduct vasomotor
responses [6, 8]. Studies in other microcirculatory ves-
sels have provided evidence that both the endothelial
and smooth muscle layers can provide pathways for the
conduction of vasodilation and vasoconstriction [9]. In
contrast, the limited connexin expression in efferent ar-
terioles ensures that afferent and efferent arterioles can
be differentially regulated. This is consistent with differ-
ences in the innervation type and density of afferent and
efferent arterioles [37]. Interestingly, the differential con-
nexin subtype expression between afferent and efferent
arterioles is matched by different anatomical and func-
tional properties of the smooth muscle cells suggestive of
a greater role for voltage dependent mechanisms in the
vessels with the greater incidence of cell coupling [38–41].
GFR is governed by a variety of factors, including
nerves, hormones, glomerular morphology, and tubu-
loglomerular feedback response [42]. During the latter
response, the resistance of afferent and efferent arteri-
oles change in opposite directions in response to alter-
ations in salt concentration in the distal tubules [43]. In
the early stages of diabetes there is a marked increase
in GFR which is associated with reduced resistance of
the afferent arterioles and diminished responsiveness to
vasoconstrictor stimuli, while responses of the efferent ar-
terioles are unchanged [44, 45]. In streptozotocin-induced
diabetes mellitus, we found a marked increase in the ex-
tent of connexin 40 expression in the smooth muscle cells
of the afferent arterioles and the appearance of connexin
43 in the renin-secreting cells. In contrast, there was a
substantial decrease in connexin 43 expression in the en-
dothelial cells of the efferent arterioles. These data sug-
gest that coupling within the preglomerular vasculature is
increased while coupling within the postglomerular vas-
culature is decreased.
Increased connexin expression in the preglomerular
vasculature might account for the observed hyperfil-
tration due to a greater ability to conduct vasodila-
tory responses through both the endothelium and the
smooth muscle to coordinate adjacent nephrons. In-
deed, during the early stages of diabetes there appears
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to be an increased activation of adenosine triphosphate
(ATP)-dependent potassium channels in afferent arteri-
oles under basal conditions and a decreased activity of
vasoconstrictors [45]. On the other hand, a decreased
coupling of the postglomerular vasculature might result
in increased intraglomerular capillary pressure, leading
to capillary damage. Within the glomerulus itself the
observed increase in coupling amongst mesangial cells
might contribute to a further increase in GFR in diabetes.
Whether these changes in connexin expression actually
result in the pathophysiology of the diabetic kidney or
are the results of adaptation to glomerular hyperfiltra-
tion awaits further experimentation.
CONCLUSION
We have for the first time demonstrated the presence of
connexin 37 coupling smooth muscle cells of smaller re-
nal arteries and arterioles and among the renin-secreting
cells and mesangial cells of C57BL/6 mice. We have also
demonstrated that there are more connexins expressed in
the preglomerular renal vasculature and juxtaglomeru-
lar apparatus than previously thought, while the post-
glomerular vasculature is poorly coupled. Our data of
connexin expression in the kidneys of diabetic mice show
that these patterns of cellular coupling are further accen-
tuated in diabetes.
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